Renata Limited

Renata Limited (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata, is one of the top ten (in terms of revenue)[1] pharmaceutical manufacturers in Bangladesh. Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products.[2] The company also manufactures animal therapeutics and nutrition products. Renata currently employs about 2300 people in its head office in Mirpur, Dhaka and its three production facilities in Mirpur, Dhaka, Rajendrapur, Gazipur and Bhaluka, Mymensingh.[3]

Renata Limited
TypeLimited Company
DSE: RENATA
IndustryPharmaceutical
Founded1993 (1993)
Headquarters
Mirpur, Dhaka
,
Bangladesh
Area served
South Asia, South East Asia, Africa, Europe and Latin America
Key people
Syed S Kaiser Kabir (CEO)
ProductsMaxpro, Rolac, Fenadin, Rolip, Furoclav and more
Number of employees
3485
Websiterenata-ltd.com

Financial data

Renata is a publicly traded company on the Dhaka Stock Exchange (ticker: RENATA).[4]

Production facilities

Recently, Renata Limited has received the UK MHRA approval for its Potent Product Facility.[5] This facility currently manufactures hormone, steroid and cytotoxic drugs,[6] and is exporting prednisolone to the UK.[7]

The company also operates four other manufacturing units – the original Pfizer facility for general products, a UNICEF-approved SFF (Sachet Filling Facility).[8]

Partnerships

Recently, GAIN (The Global Alliance for Improved Nutrition) provided US$2.9 million to Renata Limited and BRAC, one of the biggest NGOs in the developing world, to build and operate an innovative business model to produce and deliver multi-nutrient powders to vulnerable infants in Bangladesh.[9]

Constroversy

Renata was fined on 21 January 2016 by the Department of Environment for damaging the environment. The company has also illegally occupied land owned by the forest department.[10] Syed S. Kaiser Kabir, the CEO, of the company had illegally grabbed government land to build a house near Dhaka-Mymensingh highway.[11]

References
  1. Haroon, Jasim Uddin (15 February 2010). "Square tops list of 10, Incepta second". The Financial Express. Dhaka. Archived from the original on 1 October 2011.
  2. http://www.datamonitor.com/store/Product/renata_limited?productid=91312953-CEAB-43EF-8BD0-5A907E2C3ACF
  3. https://www.google.com/finance?q=DSE:RENATA
  4. "Renata Ltd (RENATA:Dhaka)". Bloomberg Businessweek. Archived from the original on 5 October 2012.
  5. Chowdhury, Raihan M. (10 November 2007). "Pharmaceutical sector development necessitates vertical integration". The Financial Express. Dhaka.
  6. http://nation.ittefaq.com/issues/2008/11/14/all0712.htm
  7. Khan, Jasim Uddin (4 June 2008). "Renata set to export medicine to Europe". The Daily Star.
  8. http://www.gainhealth.org/about-gain/participants#R
  9. http://www.gainhealth.org/press-releases/AR08-09
  10. Kantho, Kaler. "অপকর্মে বেপরোয়া রেনাটা | কালের কণ্ঠ". Kalerkantho (in Bengali). Retrieved 2018-01-10.
  11. "অপকর্মে বেপরোয়া রেনাটা". Bangladesh Pratidin (in Bengali). Retrieved 2018-01-10.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.